Two studies showcase molecular testing advancements in women's health, highlighting improved diagnosis and treatment for infectious diseases and cancer. The research reveals new insights into antimicrobial resistance, cancer recurrence risks, and tumor biology.
A new TB test developed by Northwestern University uses a tongue swab to detect Mycobacterium tuberculosis, matching the accuracy of other tests. The test can provide results within a single medical visit, enabling patients in remote areas to receive testing and care.
Prof. Dana Wolf's groundbreaking research on congenital CMV infection has advanced understanding and diagnosis, with potential for improved prevention and treatment. Her innovative approaches have also transformed public health practice, including SARS-CoV-2 testing and universal newborn screening.
Researchers explore earlier genetic diagnoses, improved cancer diagnostics, and genomic tracking of a deadly mpox outbreak in children. Studies demonstrate the potential to identify inherited conditions years before symptoms appear and improve childhood cancer testing.
A new tool, ASAP, rapidly and reversibly turns autophagy on and off, confirming suspected targets, revealing new ones, and suggesting a link between protein building and breakdown. ASAP also targets nuclear pore complexes and protein condensates, shedding light on autophagy's role in maintaining cellular health.
A study analyzing past outbreaks found most historical cases of mass mortality caused by highly pathogenic avian flu had minimal long-term effects on bird populations. The research suggests that the outbreaks may have had no significant impact on bird population size over time.
Researchers created a hybrid malaria parasite, AV27, combining the manufacturing advantages of the NF54 strain with the high liver infectivity of East African parasites. The new parasite retains the immune targets of both regions and shows improved traits, including higher sporozoite output and liver infectivity.
The National Institute of Allergy and Infectious Diseases has awarded Boston University's National Emerging Infectious Diseases Laboratories $57.5 million to develop and test a new vaccine for Ebola. The lab will support the development of research resources and facilities to address emerging infectious diseases.
The Siberian crane's population has grown, but its health is threatened by antibiotic residues and microplastic particles in its habitat. The study proposes a new approach to conservation by prioritizing population health over headcount.
ESCAIDE 2026, Europe's leading public health conference, will take place in Stockholm and online from Nov 18-20. The conference brings together leading experts to strengthen prevention and control of communicable diseases.
Ranaviruses have been detected in over 170 aquatic species, showing frequent cross-species transmission in aquaculture. The four-barrier framework for viral spillover highlights the need for early warning and prevention strategies to protect the sector.
A new study finds that antibody response in humans can persist for years, helping track melioidosis. Researchers hope this can improve diagnosis and surveillance in areas where the disease is spreading.
COVID-19 vaccines not only saved lives but also provided significant economic benefits, with global value ranging from $6.43 trillion to $64.3 trillion. The benefits were not equally distributed, with high-income countries benefiting more than low- and middle-income countries.
An Illinois farmer's backyard flock was nearly wiped out by highly pathogenic avian influenza virus, which also infected a domestic cat and wild rats. The viruses found in the animals were nearly identical, indicating a shared source and suggesting that mammalian-adaptation markers may be present in bird viruses.
A new study published in the Journal of Drug Delivery Science and Technology found that nitric oxide particles helped nine in ten infected wax moth larvae survive bacterial infections. The particles, which release nitric oxide slowly over several hours, showed promise in reducing bacterial loads by 10,000 to 100,000 times.
A prospective cohort study found that about half of people living with long COVID experienced a meaningful symptom improvement within three years. By three years, 50.1% of participants experienced a sustained symptom improvement, and 56.4% experienced substantial symptom reductions along with a good quality of life.
A new review connects functional foods, gut microbes, and host health, describing food components as signals that gut microbes transform into bioactive molecules influencing metabolism, immunity, and more. The framework highlights the potential of probiotics, prebiotics, and fermented foods to shape the gut ecosystem and calls for rigo...
A new project aims to use biochemical variables to tailor athletes' rest periods and guide young talent, with a focus on the 2028 and 2032 Paralympic Games. The project seeks to prevent infections and injuries in Paralympic athletes, who are 20 times more likely to contract infections than Olympic athletes.
A new report by ECDC suggests that universal RSV immunization of newborns could prevent up to 61% of RSV-related hospitalizations in the first two months of life. The strategy aims to reduce the burden on healthcare systems during the winter season, when RSV, influenza, and other respiratory infections are most prevalent.
Hospitalizations for drug use-associated heart infections have declined by 18% from 2020 to 2022, primarily due to a decrease in opioid cases. Stimulants, such as methamphetamine and cocaine, are increasingly involved in these infections, particularly in the Western US, highlighting the need for improved treatment options.
Cases of Ebola in Kenya and Nigeria highlight the need for preparedness, with the EU/EEA population considered at very low risk of infection. ECDC emphasizes the importance of continued preparedness and adherence to recommended precautions to prevent the spread of the virus.
A patient in France has been infected with the Shamonda virus, a disease that has previously only affected animals. The European Centre for Disease Prevention and Control is investigating the potential public health implications of this case and working with European partners to strengthen response planning.
A Tufts University-led team is advancing the development of a Lyme disease vaccine and new therapies, building on previous research that showed an engineered protein generated a strong immune response. The team aims to understand how antibodies triggered by the vaccine stop the bacterium, with potential to improve the vaccine and ident...
Professor James Ebdon, an environmental microbiologist, has been named winner of the John Snow Public Health Innovation Prize for his work on water and sanitation. He has made significant contributions to understanding the role of water and sanitation in the spread and control of water-related diseases.
Researchers have created a new antifungal drug, mandimycin M16, which selectively targets fungal ergosterol without disrupting human cholesterol. This breakthrough could lead to safer and more effective treatments for fungal infections, including multidrug-resistant strains.
Professor Stephen Obaro has been recognized for his work in applying microbiological insights to inform policy and drive systemic change. His research focuses on reducing preventable childhood deaths from infectious diseases, with evidence generated from his studies helping to inform global vaccine development and disease surveillance ...
A team of researchers from Penn State has developed a fluorescent molecular tag that tracks viral RNA and host interactions in real-time, allowing for the study of Zika and chikungunya viruses. The tool, called Mango-II, provides insight into the viral-host cell interaction, a key step to developing effective antiviral strategies.
A new Policy Brief from the UN University Institute for Water, Environment and Health argues that an equity-focused global mechanism is needed to improve vaccine financing, production, and delivery. The publication estimates that delaying the global vaccine roll-out by 100 days could have saved over 8 million lives by the end of 2021.
The 2027 Emerging Leader Awards program will provide $150,000 grants to support innovative research on Lyme disease diagnostics and therapeutics. The program aims to inspire and support promising scientists in advancing novel methodologies to benefit patients with tick-borne illnesses.
Melanie Ott and Alex Marson, directors at Gladstone Institutes, have been elected to the National Academy of Medicine for their pioneering achievements in science and medicine. Their work focuses on understanding viral mechanisms, developing innovative treatments, and repurposing human immune cells to fight disease.
A modeling study suggests that delayed or shared decision-making approaches to hepatitis B vaccination could lead to a 19-83% increase in chronic infections among US children. The current universal birth-dose strategy remains the most effective strategy for preventing childhood infections.
A new study models the impact of changing hepatitis B immunization schedules on HBV infections and susceptibility, finding delayed vaccination until 2 months old increases infections by 19% and shared decision-making by 83%, while adult susceptibility also rises significantly.
The Applied Microbiology International Horizon Awards 2026 recognize outstanding achievements in applied microbiology, with three winners announced: Professor Chris Greening for global impact, Professor Marciane Magnani for food safety and security, and Professor James Ebdon for public health innovation.
Researchers at ULiège are developing AI models to predict which HPV infections will progress to cancer, integrating biological data and aiming for more personalized care. Despite significant progress, no current biomarker allows for reliable prediction, and the complexity of HPV carcinogenesis poses a major challenge.
Researchers at UC3M and University de Zaragoza are developing AI-driven epidemiological models that can replicate human behavior during epidemics, incorporating socioeconomic factors and social determinants. The project aims to create more accurate models that can inform public health decisions and reduce existing inequalities.
The new website features a clean, intuitive architecture and interactive elements that streamline exploration of Gladstone's transformative discoveries. The site highlights the institute's core disease and technology areas, making complex scientific concepts more inviting for patients and the scientific community.
Researchers have found that a single dose of the licensed Ebola vaccine can induce T cell cross-reactivity against the Bundibugyo virus, a closely related but distinct virus. This cross-reactivity may provide a level of protection against severe disease, although more studies are needed to confirm its effectiveness.
A team of researchers discovered that Candida auris creates multiple versions of its genome, including a gene called CRZ1, which helps the fungus evade antifungal treatment. This finding opens up new avenues for treating the deadly fungus, which has already been linked to high mortality rates and costly outbreaks.
A study in mice shows that K3-SPG, a vaccine adjuvant, can activate innate immunity, providing a potential temporary defense against respiratory viruses. The treatment also protected mice against SARS-CoV-2, but its effects were mainly limited to tolerating the infection and limiting tissue damage.
Schmidt Global Health aims to improve public health systems by strengthening monitoring, analysis, and response to emerging health threats. The organization works with public health professionals to foster collaboration and coordinate emergency responses.
A new study found that people with the sickle cell variant are infected by a distinct variety of malaria parasites, which may contribute to their lower disease rates. The parasite strain is present in asymptomatic infections, differing between those with and without the sickle cell variant.
Researchers identify argyrin B as a potent therapeutic agent against C. difficile while preserving the gut microbiome. The natural compound specifically targets and kills C. difficile while leaving beneficial microorganisms intact.
Neurotic individuals were more susceptible to mental distress during the COVID-19 pandemic due to their heightened perception of risk. They also exhibited less exercise and increased alcohol consumption, further exacerbating their mental health struggles.
Researchers developed a rapid urine test to detect invasive aspergillosis, with high sensitivity and specificity rates. The test was cleared by the FDA and has shown promise in identifying cases among patients with weakened immune systems.
A new study shows that hospitals still have far to go in implementing strategies to prevent catheter-associated urinary tract infections (CAUTIs), despite 20 years of effort. The study found that only 49% of general hospitals and 32% of VA hospitals have a system in place to remind doctors of a patient's catheter status, and that highe...
Researchers developed a system of mathematical equations to examine interactions between interventions and post-infection effects. The team found that even small post-infection costs could shift the optimal vaccine coverage to higher rates, even to elimination levels.
Researchers at Juntendo University discovered a lipid signaling pathway involving 12-HHT and BLT2 that promotes plasma membrane repair and protects cells from membrane-damaging insults. Cells with enhanced BLT2 signaling showed better survival rates, less membrane leakage, and improved mitochondrial health after toxin exposure.
A new study models C. diff transmission in oncology units, revealing that asymptomatic colonized patients are the primary source of new infections. The model provides a clearer picture of C. diff transmission events and could help inform protocols to prevent future disease transmission.
Researchers identified a mechanism to kill the fungal pathogen Aspergillus fumigatus, which causes severe respiratory infections with high mortality rates. The study found that a genetic modification allowed the echinocandin drug to kill the fungus, paving the way for more targeted attacks.
Researchers have identified two pathways to repeat infection: re-infection and persistence of BV-bacteria. Tailored treatments are being trialed to improve cure rates for women with persistent bacterial vaginosis.
A study from the University of Gothenburg found that one in four patients with invasive pneumococcal disease had a marker for blood cancer or precursor conditions. Seven patients were diagnosed with blood cancer, and twelve with a condition that can progress to blood cancer.
Liangfang Zhang's invention uses human cell membranes to cloak nanoparticles, making them deliver drugs and remove toxins more effectively. The approach has shown promise against bacterial toxins, including MRSA, and may potentially treat diseases without conventional drugs.
A polyphenol-rich extract from Cistus salviifolius has shown fungicidal activity against several dermatophytes, including Trichophyton rubrum and Microsporum canis. The extract reduced fungal load and tissue invasion in a reconstructed human epidermis model, preserving the epidermal barrier and decreasing inflammation.
A blood test that compares two molecules in the blood can accurately distinguish between bacterial and viral infections in newborn babies with fever. The test showed a high sensitivity and specificity, and could potentially improve treatment and reduce unnecessary antibiotic use.
A parasite, Toxoplasma gondii, reorganizes the host cell surface to create specialized patches for entry. The parasite's invasion machinery is triggered by a specific sugar-coated protein interaction, allowing it to exploit host-cell vulnerabilities.
Researchers have identified a way to strengthen bladder cells' ability to eliminate hidden bacteria, reducing recurrent UTIs. OM-89 increases lysosomal acidification and enzyme activity, allowing antibiotics to reach and kill bacteria more effectively.
The University of Kansas has received $5.8 million in NIH funding to further its Chemical Biology of Infectious Disease center, which aims to develop targeted treatments for antibiotic-resistant pathogens. The center's collaborative approach will focus on protecting the beneficial microbiome while defeating resistance mechanisms.
A study of 3,860 nurses and midwives from 18 Latin American and Caribbean countries found recurring patterns of emotional overload, professional challenges, and exposure to multiple forms of violence during the pandemic. The researchers identified three interconnected themes: direct violence, stigma, fear, and disruption of social belo...
Researchers found strong initial protection from TB preventive treatment (TPT) in 24 countries, but long-term protection varied depending on TB disease burden. In high-burden settings, protection waned after just one year, while in low- and medium-burden settings, it lasted at least 8 and 13 years, respectively.
Candidemia, a bloodstream infection caused by Candida species, remains a major clinical challenge. The review highlights the need for rapid diagnosis, susceptibility-guided treatment, and new therapeutic approaches. Combination therapy and emerging antifungal candidates may offer new options for selected difficult infections.